Abstract
Myoclonus is defined as sudden, brief, shocklike involuntary movements caused by muscular contractions (positive myoclonus) or inhibitions (negative myoclonus). “Myoclonus” should be considered a descriptive term that refers to a symptom or sign. As with many neurologic symptoms and signs, myoclonus does not constitute a diagnosis, and it is nonspecific relative to its neuroanatomical source, its pathogenesis, and the cause of the syndrome in which it occurs. Myoclonus often has strong implications for the diagnosis, prognosis, and treatment of the underlying disorder.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected Reading
Brown P. Myoclonus: a practical guide to drug therapy. CNS Drugs 1995; 3: 22 - 29.
Caviness JN. Myoclonus. Mayo Clin Proc 1996; 71: 679 - 688.
Marsden CD, Hallett M, Fahn S. The nosology and pathophysiology of myoclonus, in Movement Disorders 1 and 2 ( Marsden CD, Fahn S eds), Edition reissue, Butterworth-Heinemann, Oxford, 1995, pp. 196 - 248.
Pranzatelli MR, Snodgrass SR. The pharmacology of myoclonus. Clin Neuropharmacol 1985; 8: 99 - 130.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Caviness, J.N. (2000). Myoclonus. In: Adler, C.H., Ahlskog, J.E. (eds) Parkinson’s Disease and Movement Disorders. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-410-8_27
Download citation
DOI: https://doi.org/10.1007/978-1-59259-410-8_27
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-095-3
Online ISBN: 978-1-59259-410-8
eBook Packages: Springer Book Archive